News Releases

Jul 27, 2021
Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021
BOULDER, Colo. --(BUSINESS WIRE)--Jul. 27, 2021-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial results for the second quarter ended June 30, 2021 after the close of trading on Tuesday,
Jun 04, 2021
Biodesix Partners with Datavant to Enhance Value of Lung Cancer Databank
Biodesix intends to make its databank and linked data accessible to research and biopharma partners BOULDER, Colo. & SAN FRANCISCO --(BUSINESS WIRE)--Jun. 4, 2021-- Biodesix, Inc.  (Nasdaq: BDSX),   a leading lung cancer diagnostic solutions company, announced a strategic partnership with Datavant,
May 25, 2021
Biodesix to Present at the William Blair 41st Annual Growth Stock Conference
BOULDER, Colo. --(BUSINESS WIRE)--May 25, 2021-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton , Chief Executive Officer of Biodesix , will present at the William Blair 41st Annual Growth Stock Conference
May 11, 2021
Biodesix Announces First Quarter 2021 Results
First Quarter 2021 Record Revenue of Approximately $28.9 Million Representing 466% Growth over First Quarter 2020 Announced Plans to Launch Two New Diagnostic Tests - SARS-CoV-2 Neutralization Antibody Detection Test and Next Generation Sequencing Test BOULDER, Colo.
Apr 26, 2021
Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021
BOULDER, Colo. --(BUSINESS WIRE)--Apr. 26, 2021-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial results for the first quarter ended March 31, 2021 after the close of trading on Tuesday,
Displaying 1 - 10 of 26